Market Mover | Shares of Mpox-related Stocks Soar After the WHO Declared the Virus a Public Health Emergency of International Concern
Market Mover | Shares of Mpox-related Stocks Soar After the WHO Declared the Virus a Public Health Emergency of International Concern
August 19, 2024 - Shares of mpox-related Drug and Vaccine Developers rise on continued strength in early trading on Monday, $Virax Biolabs (VRAX.US)$ up over 155%, $Applied DNA Sciences (APDN.US)$ up nearly 114% and $GeoVax Labs (GOVX.US)$ up more than 52%.
2024年8月19日，星期一早盤，與MPOX相關的藥物和生物-疫苗開發商的股票繼續保持強勁上漲。 $Virax Biolabs (VRAX.US)$ 增長155%以上， $Applied DNA Sciences (APDN.US)$ 增長近114%，並且 $GeoVax Labs (GOVX.US)$ 增長超過52%。
Last Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus declared that the mpox outbreak once again constituted a public health emergency of international concern (PHEIC). This is the second time relating to mpox since July 2022 that the WHO has issued such a highest-level alert. Caused by an Orthopoxvirus, mpox was first detected in humans in 1970, in the DRC. The disease is considered endemic to countries in Central and West Africa.
上週三，世界衛生組織總幹事譚德塞宣佈mpox疫情再次構成國際關注的公共衛生緊急狀態(PHEIC)。這是自2022年7月以來，世界衛生組織第二次發出最高級別警報與mpox有關。mpox由正痘病毒引起，1970年在剛果民主共和國首次發現人類病例。該疾病被認爲是中非和西非國家的地方病。
The number of suspected or confirmed mpox cases reported in Africa this year has already exceeded the total case count from last year. Currently, the mpox outbreak has extended beyond Africa, reaching Europe and Asia, with confirmed cases reported in Sweden and Pakistan.
今年非洲報告的疑似或確診mpox病例已經超過去年總病例數。目前，mpox疫情已擴散到非洲以外的地區，影響到歐洲和亞洲，瑞典和巴基斯坦已經報告了確診病例。
